Edition:
India

Acer Therapeutics Inc (ACER.OQ)

ACER.OQ on NASDAQ Stock Exchange Capital Market

17.75USD
2:29am IST
Change (% chg)

$0.45 (+2.60%)
Prev Close
$17.30
Open
$17.19
Day's High
$17.76
Day's Low
$17.19
Volume
8,140
Avg. Vol
4,342
52-wk High
$21.71
52-wk Low
$5.70

Summary

Name Age Since Current Position

Christopher Schelling

41 2017 President, Chief Executive Officer, Director

Harry Palmin

47 2017 Chief Financial Officer

William Andrews

51 2017 Chief Medical Officer

Jason Amello

2017 Director

Stephen Aselage

2017 Director

Hubert Birner

2017 Director

John Dunn

2017 Director

Michelle Griffin

2017 Director

Luc Marengere

2017 Director

Biographies

Name Description

Christopher Schelling

Mr. Christopher Schelling serves as President, Chief Executive Officer, Director of the Company. Mr. Schelling founded Private Acer in December 2013 and has served as a director of Private Acer since that time. From December 2013 to February 2016, Mr. Schelling served as Private Acer’s chief operating officer, and since February 2016 has served as Private Acer’s president and chief executive officer. Mr. Schelling also founded Apanii Consulting, LLC, a pharmaceutical and biotechnology consulting, in December 2012 and serves as the chief executive officer of that company. Prior to founding Apanii Consulting, Mr. Schelling served as executive director of BioMarin Pharmaceutical Inc., a biotechnology company, or BioMarin, where he worked on strategic marketing. Mr. Schelling earned a B.A. in biology from Carroll College.

Harry Palmin

Mr. Harry S. Palmin serves as Chief Financial Officer of the Company. Mr. Palmin has served as Private Acer’s acting chief financial officer since February 2016. Prior to that, Mr. Palmin served as the president, chief executive officer and a director of Private Acer from its founding in December 2013 until February 2016. Prior to joining Private Acer, Mr. Palmin served in a variety of roles at Novelos Therapeutics, Inc., a pharmaceutical company, including president and director from 1998 to October 2013, chief executive officer from January 2005 to October 2013 and acting chief financial officer from 1998 to September 2005. Mr. Palmin earned a B.A. in economics from Brandeis University and a M.A. in international economics and finance from the Brandeis University International Business School.

William Andrews

Mr. William T. Andrews is Chief Medical Officer of the company. He joins Acer Therapeutics as Chief Medical Officer after having worked in the biotech/pharmaceutical industry for 17 years in both Clinical Development and Medical Affairs in multiple therapeutic areas, with a focus and extensive experience in rare diseases. Dr. Andrews has significant medical marketplace and product launch experience, having served as the medical lead for six product launches, including Xopenex HFA®, Brovana®, Alvesco®, Omnaris®, Catena®, and Juxtapid®. Most recently, he provided strategic consulting services to rare disease companies in Clinical Development, Medical Affairs, Go-To-Market/Launch planning, and Business Development/Corporate Strategy. Previously, Dr. Andrews held senior leadership positions and positions of increasing responsibility at Aegerion Pharmaceuticals, Santhera Pharmaceuticals, Sepracor, and ClinQuest. He received his undergraduate degree in Biology from Harvard University and his M.D. degree from Yale University School of Medicine. Dr. Andrews practiced medicine for 7 years full-time and 11 years part-time in the Boston area as a board-certified Internist and an Attending Physician at Brigham and Women’s Hospital, and was on the Clinical Faculty at Harvard Medical School.

Jason Amello

Mr. Jason Amello serves as Director of Acer Therapeutics, Inc.

Stephen Aselage

Mr. Stephen J. Aselage serves as Director of Acer Therapeutics, Inc.

Hubert Birner

Dr. Hubert Birner serves as Director of the Acer Therapeutics, Inc.

John Dunn

Mr. John M. Dunn serves as Director of Acer Therapeutics, Inc.

Michelle Griffin

Ms. Michelle Griffin serves as Director of Acer Therapeutics, Inc.

Luc Marengere

Dr. Luc Marengere serves as Director of Acer Therapeutics, Inc.